Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03459079
What this trial is testing

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Type 2 Diabetes (T2DM)
University of Florida 128
Not applicableActive Not RecruitingNCT06724913
What this trial is testing

Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice Cream (Ice Cream With Brazzein, Maltitol and Oligofructose; Ice Cream With Brazzein, Erythritol, Maltitol and Inulin) Compared to Standard (Sundae) Ice Cream

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)Diabetes Mellitus Type 2 (T2DM)
Federal State Budgetary Scientific Institution 100
Not applicableUnknownNCT05041673
What this trial is testing

Anti-diabetic Drugs and Fatty Liver Management

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Alexandria University 120
Post-approval studies (Phase 4)UnknownNCT03950505
What this trial is testing

To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes

Who this might be right for
Non-alcoholic SteatohepatitisType2 Diabetes
Yonsei University 60
Not applicableActive Not RecruitingNCT06053177
What this trial is testing

Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes

Who this might be right for
Type 2 DiabetesPre DiabetesObstructive Sleep Apnea+2 more
University of Liverpool 400
Not applicableStudy completedNCT05092399
What this trial is testing

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLDObesity
University of Nottingham 21
Not applicableEnded earlyNCT03365531
What this trial is testing

RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLDObesityDiabetes Mellitus, Type 2
University of Florida 7
Not applicableStudy completedNCT04283942
What this trial is testing

Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism

Who this might be right for
Fatty Liver DiseaseType 2 DiabetesImpaired Glucose Regulation
Shanghai Zhongshan Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06151964
What this trial is testing

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Who this might be right for
Overweight and Obesity
AstraZeneca 166
Large-scale testing (Phase 3)Study completedNCT06117137
What this trial is testing

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Fatty Liver, Nonalcoholic
Sohag University 150
Not applicableUnknownNCT06144593
What this trial is testing

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Overweight and ObesityNon-Alcoholic Fatty Liver Disease+1 more
Hvidovre University Hospital 14
Post-approval studies (Phase 4)UnknownNCT01720719
What this trial is testing

Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverDyslipidemiasDiabetes Mellitus
Xin Gao 120
Not applicableStudy completedNCT04820556
What this trial is testing

Gut Microbiota in Chronic Noncommunicable Diseases

Who this might be right for
Arterial HypertensionAtherosclerosis Occlusive DiseaseHeart Failure With Preserved Ejection Fraction+5 more
National Medical Research Center for Therapy and Preventive Medicine 1,084
Not applicableUnknownNCT03073343
What this trial is testing

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Insulin Dependent DiabetesALT
Southern California Institute for Research and Education 48
Post-approval studies (Phase 4)UnknownNCT06218342
What this trial is testing

Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease

Who this might be right for
Type 2 DiabetesNon-Alcoholic Fatty Liver Disease
Sir Run Run Shaw Hospital 156
Post-approval studies (Phase 4)Study completedNCT07363707
What this trial is testing

A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)
Beni-Suef University 108
Testing effectiveness (Phase 2)Study completedNCT05232071
What this trial is testing

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

Who this might be right for
NASH - Nonalcoholic SteatohepatitisDiabetes Mellitus, Type 2
Inventiva Pharma 39
Not applicableStudy completedNCT05044130
What this trial is testing

Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD

Who this might be right for
NAFLDType 2 Diabetes
University of Aarhus 17
Not applicableLooking for participantsNCT06649162
What this trial is testing

Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy

Who this might be right for
Type 2 Diabetes
Boryung Pharmaceutical Co., Ltd 10,000
Post-approval studies (Phase 4)UnknownNCT05872269
What this trial is testing

Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Who this might be right for
NAFLDObesityType 2 Diabetes+2 more
Zydus Lifesciences Limited 1,500
Next Page